Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain

Journal of Pharmacology and Experimental Therapeutics

Volumn 297, Issue 3, 2001, Pages 991-1000

  Sun, Haiying ^a   Bungay, Peter M ^b   Elmquist, William F ^a,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c 986025 Nebraska Medical Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN; GLYCOPROTEIN P; PROBENECID; PROTEIN INHIBITOR; QUINIDINE; ZOSUQUIDAR;

ANIMAL EXPERIMENT; ANION TRANSPORT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CALCULATION; CONTROLLED STUDY; DRUG TRANSPORT; EXTRACELLULAR FLUID; FRONTAL CORTEX; IN VIVO STUDY; MALE; MATHEMATICAL MODEL; MEMBRANE TRANSPORT; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANION TRANSPORT PROTEINS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARY PERMEABILITY; CARRIER PROTEINS; CROSS-OVER STUDIES; DIBENZOCYCLOHEPTENES; FLUORESCEINS; FLUORESCENT DYES; FRONTAL LOBE; MALE; MICRODIALYSIS; MODELS, BIOLOGICAL; P-GLYCOPROTEIN; PROBENECID; QUINIDINE; QUINOLINES; RATS; RATS, WISTAR; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0034998423     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Amberg G and Lindefors N (1989) Intracerebral microdialysis. II. Mathematical studies of diffusion kinetics. J Pharmacol Methods 22:157-183.
2. Beagles KE, Morrison PF and Heyes MP (1998) Quinolinic acid in vivo synthesis rates, extracellular concentrations, and intercompartmental distributions in normal and immune-activated brain as determined by multiple-isotope microdialysis. J Neurochem 70:281-291.
3. Benveniste H and Huttemeier PC (1990) Microdialysis - theory and application. Prog Neurobiol 35:195-215.
4. Bungay PM, Morrison PF and Dedrick RL (1990) Steady state theory for quantitative microdialysis of solutes and water in vivo and in vitro. Life Sci 46:105-119.
5. Bungay PM, Dedrick RL, Fox E and Balis FM (2001) Probe calibration in transient microdialysis in vivo. Pharm Res, in press.
6. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR and Bertino JR (1989) Multidrug-resiatance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86:695-698.
7. Cosford RJ, Vinson AP, Kukoyi S and Justice JB Jr (1996) Quantitative microdialysis of serotanin and norepinephrine: pharmacological influences on in vivo extraction fractions. J Neurosci Methods 68:39-47.
8. Dantzig AH, Shepard RL, Cao J, Law KL, Ehlhardt WJ, Baughman TM, Bumol TF, and Starling JJ (1996) Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. Cancer Res 56: 4171-4179.
9. Dantzig AH, Shepard RL, Law KL, Tabas L, Pratt S, Gillespie JS, Binkley SN, Kuhfeld MT, Starling JJ and Wrighton SA (1999) Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities. J Pharmacol Exp Ther 290:854-862.
10. de Lange ECM, de Bock G, Schinkel AH, de Boer AB and Breimer DD (1998) BBB transport and P-glycoprotein functionality using MDR1a (-/-) and wild-type mice: total brain versus microdialysis concentration profiles of rhodamine-123. Pharm Res 15:1657-1665.
11. Desrayaud S, Guntz P, Scherrmann J-M and Lemaire M (1997) Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicine. Life Sci 61:153-163.
12. Dykstra KH, Hsiao JK, Morrison PF, Bungay PM, Mefford IN, Scully MM and Dedrick RL (1992) Quantitative examination of tissue concentration profiles associated with microdialysis. J Neurochem 58:931-940.
13. Dykstra KH, Arya A, Arriola DM, Bungay PM, Morrison PF and Dedrick RL (1993) Microdialysis study of zidovudine (AZT) transport in rat brain. J Pharmacol Exp Ther 267:1227-1235.
14. Elmquist WF and Sawchuk RJ (1997) Application of microdialysis in pharmacokinetic studies. Pharm Res 14:267-288.
15. Engler CB, Sander B, Larsen M, Koefoed P, Parving HH and Lund-Andersen H (1994) Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier. Acta Ophthalmol (Copenh) 72:663-667.
16. Fromm MF (2000) P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int J Clin Pharmacol Ther 38:69-74.
17. Huai-Yun H, Secrest DT, Mark KS, Carney D, Brandquist C, Elmquist WF and Miller DW (1998) Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochem Biophys Res Commun 243:816-820.
18. Kusuhara H, Suzuki H, Terasaki T, Kakee A, Lemaire M and Sugiyama Y (1997) P-glycoprotein mediates the efflux of quinidine across the blood-brain barrier. J Pharmacol Exp Ther 283:574-580.
19. Morrison PF, Bungay PM, Hsiao JK, Ball BA, Mefford IN and Dedrick RL (1991) Quantitative microdialysis: analysis of transients and application to pharmacokinetics in brain. J Neurochem 57:103-119.
20. Morrison PF, Morishige GM, Beagles KE and Heyes MP (1999) Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: a quantitative analysis. J Neurochem 72:2135-2144.
21. Patlak CS and Fenstermacher JD (1975) Measurements of dog blood-brain transfer constants by ventriculocisternal perfusion. Am J Physiol 229:877-884.
22. Rao VV, Dahlheimer JL, Bardgett ME, Snyder AZ, Finch RA, Sartorelli A and Piwnica-Worms D (1999) Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal fluid drug-permeability barrier. Proc Natl Acad Sci USA 96:3900-3905.
23. Smith AD and Justice JB (1994) The effect of inhibition of synthesis, release, metabolism and uptake on the microdialysis extraction fraction of dopamine. J Neurosci Methods 54:75-82.
24. Starling JJ, Shepard RL, Cao J, Law KL, Norman BH, Kroin JS, Ehlhardt WJ, Baughman TM, Winter MA, Bell MG, et al. (1997 Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoprotein. Adv Enzyme Regul 37:335-347.
25. Stein WD (1997) Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol Rev 77:545-590.
26. Sun H, Miller DW and Elmquist WF (1998) MRP-mediated drug transport in the central nervous system: an in vivo microdialysis study in freely-moving rats. PharmSci 1:S-567.
27. Vinson PN and Justice JB Jr (1997) Effect of neostigmine on concentration and extraction fraction of acetylcholine using quantitative microdialysis. J Neurosci Methods 73:61-67.
28. Wang Y, Wong SL and Sawchuk RJ (1993) Microdialysis calibration using retrodialysis and zero-net flux: application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus. Pharm Res 10:1411-1419.
29. Wang Q, Yang H, Miller DW and Elmquist WF (1995) Effect of the P-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats. Biochem Biophys Res Commun 211: 719-726.
30. Wang Q, Yang H and Elmquist WF (1996) The effect of LY-335979 on the distribution kinetics of quinidine to the brain: an in vivo microdialysis study in freely-moving rats. Pharm Res 13:S-456.
31. Wong SL, van Belle K and Sawchuk RJ (1993) Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis. J Pharmacol Exp Ther 264:899-909.
32. Yang H, Wang Q and Elmquist WF (1996) Fluconazole distribution to the brain: a crossover study in freely-moving rats using in vivo microdialysis. Pharm Res 13: 1570-1575.